NCT04646005
Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy
Phase: Phase 2
Role: Collaborator
Start: Jun 28, 2021
Completion: May 29, 2024